Daily intraperitoneal BIIE 0246 increased insulin and HOMA-IR in chow-fed wild-type mice and homozygous transgenic male OE-NPYDβH animals, but not in DIO. In male Yorkshire pigs, intravenous BIIE 0246 significantly reduced the effects of bilateral stellate ganglia stimulation on left ventricular systolic pressure in the pre-BIIE versus post-BIIE comparison. In male BALB/c mice, albuminuria was significantly reduced in the ADR+BIIE0246 group compared with the ADR+Vehicle group at 14 d. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Insulin responses in wild-type mice
Animal study · WT mice on a C57Bl/6N background; WT (n = 11–13) [1]
Wild-type mice received daily intraperitoneal BIIE 0246 at 1.3 mg/kg. Treatment increased insulin and HOMA-IR in chow-fed groups but not in DIO.
Conditions shared by the study groups
- Route
- intraperitoneal (i.p.) injections
- Treatment course
- daily intraperitoneal (i.p.) injections; a chow diet-fed cohort after 4.5 weeks of treatment and a Western diet-fed cohort after 2 weeks of treatment
- Vehicle
- vehicle (DMSO, Tween® 80) (Fisher Scientific, Fair Lawn, NJ, United States and 0.9% NaCl, 1:1:18, respectively)
- BIIE 0246 1.3 mg/kg
- Model: WT mice on a C57Bl/6N background; WT (n = 11–13)
Methods and source locations
Compound reported in the paper: BIIE 0246
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animals (S1); Materials and Methods > Experimental Procedures (S14); Results > Blood Glucose and Lipids (S61); Table 1 legend (S114, S115); Table 1 (T1.h2, T1.h3, T1.r2)
Insulin (μg l-1): Insulin (μg l-1); comparator: Vehicle — Results > Blood Glucose and Lipids (S61); Table 1 legend (S114); Table 1 (T1.h2, T1.h3, T1.r2)
BIIE 0246 1.3 mg/kg · Materials and Methods > Experimental Procedures (S14); Results > Blood Glucose and Lipids (S61); Table 1 legend (S114); Table 1 (T1.h2, T1.h3, T1.r2)
Ventricular pressure response during sympathetic stimulation in pigs
Animal study · male Yorkshire pigs; n = 8 [2]
Male Yorkshire pigs received an intravenous BIIE bolus followed by infusion. In the pre-BIIE versus post-BIIE comparison, the effects of bilateral stellate ganglia stimulation on left ventricular systolic pressure were significantly reduced post-BIIE.
Conditions shared by the study groups
- Route
- infused intravenously
- Treatment course
- A 20-min acclimation period with continuous infusion of BIIE; during the first 45 s of sympathetic stimulation prior to VNS
- BIIE 0246 32 nmol/kg bolus followed by a 2 nmol/kg/min infusion
- Model: male Yorkshire pigs; n = 8
- Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations
Compound reported in the paper: BIIE 0246
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Methods > Porcine studies > Experimental protocol (S25); Methods > Porcine studies > Stellate ganglia stimulations (S49); Methods > Porcine studies > Infusion of Y2R blocker (S59, S60); Results > Effects of muscarinic blockade on NPY in vivo (S92); Results > Haemodynamic and electrophysiological effects of BSS pre- vs. post-BIIE administration (S98, S100); Figure 3 legend (S140, S141); Figure 4 legend (S150)
left ventricular systolic pressure (LVSP): left ventricular systolic pressure (LVSP); comparator: BSS pre- vs. post-BIIE — Results > Effects of muscarinic blockade on NPY in vivo (S92); Results > Haemodynamic and electrophysiological effects of BSS pre- vs. post-BIIE administration (S100)
BIIE 0246 32 nmol/kg bolus followed by a 2 nmol/kg/min infusion · Methods > Porcine studies > Infusion of Y2R blocker (S59, S60); Results > Haemodynamic and electrophysiological effects of BSS pre- vs. post-BIIE administration (S98, S100)
Albuminuria response in Adriamycin-treated mice
Animal study · male BALB/c mice [3]
Male BALB/c mice receiving Adriamycin were treated with BIIE 0246 by daily intraperitoneal injection or subcutaneous osmotic minipump. Albuminuria was significantly reduced in the ADR+BIIE0246 group compared with the ADR+Vehicle group.
Conditions shared by the study groups
- Route
- daily intraperitoneal (i.p.) injection or subcutaneous osmotic minipump
- Treatment course
- for 14 d
- Vehicle
- dimethylsulfoxide (BIIE0246 vehicle)
- BIIE 0246 10 μg/day
- Model: male BALB/c mice
Methods and source locations
Compound reported in the paper: BIIE 0246
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Inhibiting NPY2R In Vivo Reduces Albuminuria in Adriamycin Nephropathy. (S41); Materials and Methods > Animal Studies. (S77); Fig. 8. legend (S140, S141, S143, S144)
uACRs: uACRs; comparator: ADR+Vehicle group — Fig. 8. legend (S143, S144)
BIIE 0246 10 μg/day · Results > Inhibiting NPY2R In Vivo Reduces Albuminuria in Adriamycin Nephropathy. (S41); Materials and Methods > Animal Studies. (S77); Fig. 8. legend (S144)
Insulin responses in transgenic animals
Animal study · Homozygous transgenic male OE-NPYDβH; C57Bl/6N background; NPY (n = 11–12) [1]
Homozygous transgenic male OE-NPYDβH animals received daily intraperitoneal BIIE 0246 at 1.3 mg/kg. Treatment increased insulin and HOMA-IR in chow-fed groups but not in DIO.
Conditions shared by the study groups
- Route
- intraperitoneal (i.p.) injections
- Treatment course
- daily intraperitoneal (i.p.) injections; a chow diet-fed cohort after 4.5 weeks of treatment and a Western diet-fed cohort after 2 weeks of treatment
- Vehicle
- vehicle (DMSO, Tween® 80) (Fisher Scientific, Fair Lawn, NJ, United States and 0.9% NaCl, 1:1:18, respectively)
- BIIE 0246 1.3 mg/kg
- Model: Homozygous transgenic male OE-NPYDβH; C57Bl/6N background; NPY (n = 11–12)
Methods and source locations
Compound reported in the paper: BIIE 0246
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Materials and Methods > Animals (S1); Materials and Methods > Experimental Procedures (S14); Results > Blood Glucose and Lipids (S61); Table 1 legend (S114, S115); Table 1 (T1.h2, T1.h3, T1.r2)
Insulin (μg l-1): Insulin (μg l-1); comparator: Vehicle — Results > Blood Glucose and Lipids (S61); Table 1 legend (S114); Table 1 (T1.h2, T1.h3, T1.r2)
BIIE 0246 1.3 mg/kg · Materials and Methods > Experimental Procedures (S14); Results > Blood Glucose and Lipids (S61); Table 1 legend (S114); Table 1 (T1.h2, T1.h3, T1.r2)